TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
25,356
|
22,276
|
6,887 |
Financial expenses |
26
|
0
|
13 |
Earnings before taxes |
-1,833
|
2,203
|
-6,750 |
EBITDA |
-1,713
|
2,256
|
-6,708 |
Total assets |
101,410
|
96,278
|
99,142 |
Current assets |
24,107
|
34,051
|
43,708 |
Current liabilities |
6,877
|
6,805
|
9,193 |
Equity capital |
94,532
|
89,473
|
89,949 |
- share capital |
2,721
|
2,541
|
2,619 |
Employees (average) |
13
|
10
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.2%
|
92.9%
|
90.7% |
Turnover per employee |
1,950
|
2,228
|
765 |
Profit as a percentage of turnover |
-7.2%
|
9.9%
|
-98.0% |
Return on assets (ROA) |
-1.8%
|
2.3%
|
-6.8% |
Current ratio |
350.5%
|
500.4%
|
475.4% |
Return on equity (ROE) |
-1.9%
|
2.5%
|
-7.5% |
Change turnover |
1,499
|
15,596
|
3,283 |
Change turnover % |
6%
|
233% | |
Chg. No. of employees |
3
|
1
![]() |
1 |
Chg. No. of employees % |
30%
|
11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.